Portland, OR — (PRESS RELEASE JET) — 10/30/2017 — Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses
The growth in the incidence of orthopaedic diseases & chronic pain are anticipated to augment the market growth. Furthermore, rise in disposable income and surge in the global geriatric population are expected to propel the global opioids market. However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market.
Get the sample copy of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/3556
The global opioid market is segmented on the basis of product type, application, and geography. Based on product type, it is divided into codeine, fentanyl, meperidine, methadone, morphine, and hydrocodone. On the basis of application, the market is divided into pain management, cough treatment, and diarrhea treatment. The pain management segment is further classified into neuropathic pain, migraine, back pain, osteoarthritis pain, cancer pain, and others.
Make a purchase enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3556
Comprehensive competitive analysis and profiles of major market players such as Purdue Pharma, Titan Pharmaceuticals, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., Allergan, Plc, Pfizer, Inc. have also been provided in this report.
Opioids Market Key Segments:
By Product Type
Powered by WPeMatico